BMY-28100, A NEW ORAL CEPHALOSPORIN - ANTIMICROBIAL ACTIVITY AGAINST NEARLY 7,000 RECENT CLINICAL ISOLATES, COMPARATIVE POTENCY WITH OTHER ORAL-AGENTS, AND ACTIVITY AGAINST BETA-LACTAMASE PRODUCING ISOLATES

被引:24
作者
JONES, RN
BARRY, AL
机构
关键词
D O I
10.1016/0732-8893(88)90056-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:11 / 26
页数:16
相关论文
共 21 条
[1]   CEFADROXIL, A NEW BROAD-SPECTRUM CEPHALOSPORIN [J].
BUCK, RE ;
PRICE, KE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (02) :324-330
[2]   COMPARATIVE ANTIBACTERIAL ACTIVITY OF A NEW ORAL CEPHALOSPORIN, BMY-28100 [J].
CHIN, NX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (03) :480-483
[3]   INVITRO ACTIVITY OF BMY-28100, A NEW ORAL CEPHALOSPORIN [J].
ELIOPOULOS, GM ;
REISZNER, E ;
WENNERSTEN, C ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (04) :653-656
[4]   INVITRO ACTIVITIES OF RO-19-5247 AND RO-15-8074, NEW ORAL CEPHALOSPORINS [J].
FASS, RJ ;
HELSEL, VL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (03) :429-434
[5]   STABILITY AND BLOOD LEVEL DETERMINATIONS OF CEFACLOR, A NEW ORAL CEPHALOSPORIN ANTIBIOTIC [J].
FOGLESONG, MA ;
LAMB, JW ;
DIETZ, JV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 13 (01) :49-52
[6]   INVITRO EVALUATION OF CEFIXIME (FK027, FR17027, CL284635) - SPECTRUM AGAINST RECENT CLINICAL ISOLATES, COMPARATIVE ANTIMICROBIAL ACTIVITY, BETA-LACTAMASE STABILITY, AND PRELIMINARY SUSCEPTIBILITY TESTING CRITERIA [J].
FUCHS, PC ;
JONES, RN ;
BARRY, AL ;
THORNSBERRY, C ;
AYERS, LW ;
GAVAN, TL ;
GERLACH, EH .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1986, 5 (02) :151-162
[7]  
GUAY DRP, 1986, ANTIMICROB AGENTS CH, V30, P483
[8]   ANTIMICROBIAL ACTIVITY OF RO-15-8074, ACTIVE METABOLITE OF A NEW ORAL CEPHALOSPORIN (RO-15-8075), AGAINST 7,775 RECENT CLINICAL ISOLATES [J].
JONES, RN ;
FUCHS, PC ;
BARRY, AL ;
AYERS, LW ;
GERLACH, EH ;
GAVAN, TL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (06) :961-963
[9]  
JONES RN, 1983, POSTGRAD MED J, V59, P9